1. Home
  2. XERS vs MQY Comparison

XERS vs MQY Comparison

Compare XERS & MQY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XERS
  • MQY
  • Stock Information
  • Founded
  • XERS 2005
  • MQY 1994
  • Country
  • XERS United States
  • MQY United States
  • Employees
  • XERS N/A
  • MQY N/A
  • Industry
  • XERS Biotechnology: Pharmaceutical Preparations
  • MQY Investment Bankers/Brokers/Service
  • Sector
  • XERS Health Care
  • MQY Finance
  • Exchange
  • XERS Nasdaq
  • MQY Nasdaq
  • Market Cap
  • XERS 752.7M
  • MQY 799.5M
  • IPO Year
  • XERS 2018
  • MQY N/A
  • Fundamental
  • Price
  • XERS $5.29
  • MQY $11.01
  • Analyst Decision
  • XERS Strong Buy
  • MQY
  • Analyst Count
  • XERS 6
  • MQY 0
  • Target Price
  • XERS $6.25
  • MQY N/A
  • AVG Volume (30 Days)
  • XERS 2.2M
  • MQY 184.8K
  • Earning Date
  • XERS 08-07-2025
  • MQY 01-01-0001
  • Dividend Yield
  • XERS N/A
  • MQY 4.73%
  • EPS Growth
  • XERS N/A
  • MQY N/A
  • EPS
  • XERS N/A
  • MQY N/A
  • Revenue
  • XERS $222,551,000.00
  • MQY N/A
  • Revenue This Year
  • XERS $35.03
  • MQY N/A
  • Revenue Next Year
  • XERS $18.31
  • MQY N/A
  • P/E Ratio
  • XERS N/A
  • MQY N/A
  • Revenue Growth
  • XERS 29.88
  • MQY N/A
  • 52 Week Low
  • XERS $2.10
  • MQY $9.82
  • 52 Week High
  • XERS $6.07
  • MQY $12.52
  • Technical
  • Relative Strength Index (RSI)
  • XERS 62.91
  • MQY 46.46
  • Support Level
  • XERS $5.00
  • MQY $11.07
  • Resistance Level
  • XERS $5.49
  • MQY $11.12
  • Average True Range (ATR)
  • XERS 0.24
  • MQY 0.07
  • MACD
  • XERS 0.08
  • MQY -0.00
  • Stochastic Oscillator
  • XERS 79.38
  • MQY 21.67

About XERS Xeris Biopharma Holdings Inc.

Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).

About MQY Blackrock MuniYield Quality Fund Inc.

Blackrock Muniyield Quality Fund Inc is a closed-end management investment company. The company's objective is to provide shareholders with as high a level of current income exempt from U.S. federal income taxes as is consistent with its investment policies and prudent investment management. The company invests in Transportation, Corporate, Health, Utilities, Education, Housing, and other sectors.

Share on Social Networks: